Feed / CAPR

Capricor Therapeutics, Inc.

CAPR

Healthcare · 8.31 +22.1% today

Isolated · not yet confirmedMarket checked 25 Aug, 15:55 GMT-4

Jodie situation report

Capricor Therapeutics, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 2 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 6 directly disclosed connections are confirming.

Company+22.1% todayVolume comparison unavailable
Market group0 of 2 activeExosome Therapeutics & Commerce · unavailable
Disclosed network0 of 6 confirmingNo filing-linked name is confirming now
What would change this read
  • CAPR's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if CAPR's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind CAPR

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

TMOThermo Fisher Scientific IncsupplierMar 17, 2026

13 Table of Contents Cell Line License Agreement with Life Technologies On March 7, 2022, Capricor entered into a non-exclusive cell line license agreement with Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, Inc., for the supply of c…

OPYOppenheimer Holdings, Inc.partnerNov 10, 2025

g under a prospectus supplement for aggregate sales proceeds of up to $150.0 million (the “September 2025 ATM Program”) on September 10, 2025, pursuant to an Equity Distribution Agreement with Piper Sandler and Oppenheimer (collectively, the “Agents”) by whic…

Depended on by

BCDABioCardia, Inc.competitorMar 24, 2026

The industry continues to expand and evolve as an increasing number of competitors and potential competitors enter the market, including AstraZeneca, Bayer, Blue Rock Therapeutics, Bristol-Myers Squibb, Lisata Therapeutics, Capricor Therapeutics, Celixir, Cel…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

CAPR is currently a Leader in the organic co-movement group Exosome Therapeutics & Commerce. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for CAPR; it is not active in the latest market snapshot.